Milestone Pharmaceuticals Inc. (MIST) Reports First Patient Enrolled In NODE-303 Open-Label Safety Study Of Etripamil In PSVT
Milestone Pharmaceuticals Inc. (MIST) Reports First Patient Enrolled In NODE-303 Open-Label Safety Study Of Etripamil In PSVT
October 03, 2019